BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 18395683)

  • 1. Sex steroids and vascular responses in hypertension and aging.
    Qiao X; McConnell KR; Khalil RA
    Gend Med; 2008; 5 Suppl A():S46-64. PubMed ID: 18395683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.
    Khalil RA
    Biochem Pharmacol; 2013 Dec; 86(12):1627-42. PubMed ID: 24099797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.
    Ross RL; Serock MR; Khalil RA
    Curr Cardiol Rev; 2008 Nov; 4(4):309-22. PubMed ID: 20066139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular effects of estrogenic menopausal hormone therapy.
    Reslan OM; Khalil RA
    Rev Recent Clin Trials; 2012 Feb; 7(1):47-70. PubMed ID: 21864249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.
    do Nascimento GR; Barros YV; Wells AK; Khalil RA
    Curr Hypertens Rev; 2009 Nov; 5(4):283-306. PubMed ID: 20694192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency states associated with menopause.
    Serock MR; Wells AK; Khalil RA
    Recent Pat Cardiovasc Drug Discov; 2008 Nov; 3(3):165-86. PubMed ID: 18991792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex hormones, vascular function and the outcome of hormone replacement therapy in cardiovascular disease.
    Khalil RA
    Future Cardiol; 2007 May; 3(3):283-300. PubMed ID: 19804220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related reduction in estrogen receptor-mediated mechanisms of vascular relaxation in female spontaneously hypertensive rats.
    Wynne FL; Payne JA; Cain AE; Reckelhoff JF; Khalil RA
    Hypertension; 2004 Feb; 43(2):405-12. PubMed ID: 14699001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.
    Masood DE; Roach EC; Beauregard KG; Khalil RA
    Curr Drug Metab; 2010 Oct; 11(8):693-714. PubMed ID: 21189141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormones as potential modulators of vascular function in hypertension.
    Khalil RA
    Hypertension; 2005 Aug; 46(2):249-54. PubMed ID: 15983238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.
    Khalil RA
    Cardiovasc Hematol Agents Med Chem; 2010 Jan; 8(1):29-46. PubMed ID: 20210774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.
    Smiley DA; Khalil RA
    Curr Med Chem; 2009; 16(15):1863-87. PubMed ID: 19442151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender, sex hormones, and vascular tone.
    Orshal JM; Khalil RA
    Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R233-49. PubMed ID: 14707008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor subtypes mediate distinct microvascular dilation and reduction in [Ca2+]I in mesenteric microvessels of female rat.
    Mazzuca MQ; Mata KM; Li W; Rangan SS; Khalil RA
    J Pharmacol Exp Ther; 2015 Feb; 352(2):291-304. PubMed ID: 25472954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis".
    Sowers MR; Randolph J; Jannausch M; Lasley B; Jackson E; McConnell D
    Arch Intern Med; 2008 Oct; 168(19):2146-53. PubMed ID: 18955645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in the regulation of vascular tone.
    Thompson J; Khalil RA
    Clin Exp Pharmacol Physiol; 2003; 30(1-2):1-15. PubMed ID: 12542447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term hormone therapy improves sCD40L and endothelial function in early menopausal women: potential role of estrogen receptor polymorphisms.
    Bechlioulis A; Naka KK; Kalantaridou SN; Chatzikyriakidou A; Papanikolaou O; Kaponis A; Vakalis K; Vezyraki P; Gartzonika K; Mavridis A; Georgiou I; Michalis LK
    Maturitas; 2012 Apr; 71(4):389-95. PubMed ID: 22277987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of estrogen effects on the endothelium: an overview.
    Chakrabarti S; Morton JS; Davidge ST
    Can J Cardiol; 2014 Jul; 30(7):705-12. PubMed ID: 24252499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.